Altogether, the results indicate that the synergistic effect of icotinib and BDMD on NSCLC cell growth inhibition can be partially attributed to upregulation of VDAC1, accumulation of ROS and mitochondrial-mediated apoptosis. The gene discussed is VDAC1; the disease is non-small cell lung carcinoma.